Medical device maker Boston Scientific Corp. plans to pay more than $200 million to buy the remaining stake in a device company called Cryterion Medical, which owns an invention that uses a burst ...

Boston Scientific Corp. (BSX) on Thursday said it agreed to buy the roughly 65% of Cryterion Medical Inc. it doesn’t already own for $202 million in cash. Cryterion is developing a single-shot ...

Boston Scientific is acquiring Cryterion Medical, a company the medical device giant has invested in since its launch in 2016, by buying up the remaining 65% stake for $202 million upfront as ...

Cryterion Medical is developing a treatment for atrial fibrillation, or irregular heartbeat. Boston Scientific has been an investor in the company since it was launched in 2016. Boston Scientific ...

MARLBOROUGH, Mass., July 5, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Cryterion Medical, Inc., a privately-held company ...

Boston Scientific CorporationBSX recently announced the acquisition of Cryterion Medical, Inc. - a privately-held developer of a single-shot cryoablation platform for the treatment of atrial ...

Boston Scientific Corp. has inked an agreement to acquire the rest of Cryterion Medical Inc. it does not own for $202 million in up-front cash. The attraction of Cryterion, of Carlsbad, Calif., is the ...